Exane Derivatives’s TD Ameritrade Holding Corp AMTD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,046
Closed -$152K 747
2019
Q1
$152K Sell
3,046
-704
-19% -$38.1K 0.03% 258
2018
Q4
$184K Hold
3,750
0.03% 260
2018
Q3
$200K Sell
3,750
-118
-3% -$6.71K 0.04% 243
2018
Q2
$215K Sell
3,868
-1,814
-32% -$108K 0.04% 257
2018
Q1
$325K Buy
5,682
+130
+2% +$7.37K 0.07% 187
2017
Q4
$284K Buy
+5,552
New +$277K 0.05% 207

Other funds holding AMTD

Exane Derivatives's AMTD Position: Q2 2019 in Review

Exane Derivatives sold out of TD Ameritrade Holding Corp (AMTD) in Q2 2019, closing a stake of 3,046 shares — an estimated $152K sold.

Exane Derivatives first reported a position in AMTD in Q4 2017 and held it in 6 quarters. The position peaked at $325K in Q1 2018. 397 funds tracked by Wall St. Rank hold AMTD as of Q2 2019.

  • Exane Derivatives reported no remaining TD Ameritrade Holding Corp position as of Q2 2019 after selling out during the quarter.
  • Exane Derivatives sold 3,046 TD Ameritrade Holding Corp shares in Q2 2019, an estimated $152K.
  • Exane Derivatives first reported a position in TD Ameritrade Holding Corp in Q4 2017 and held it in 6 quarters.
  • Exane Derivatives's TD Ameritrade Holding Corp position peaked at $325K in Q1 2018.
  • 397 funds tracked by Wall St. Rank held TD Ameritrade Holding Corp as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.